| 1 | 
                
                    URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 339).
                    
                        
                    
                 | 
            
                        
                | 2 | 
                
                    Discovery of a potent and selective prostaglandin D2 receptor antagonist, [(3R)-4-(4-chloro-benzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydroc... J Med Chem. 2007 Feb 22;50(4):794-806.
                    
                        
                    
                 | 
            
                        
                | 3 | 
                
                    Setipiprant, a selective CRTH2 antagonist, reduces allergen-induced airway responses in allergic asthmatics. Clin Exp Allergy. 2014 Aug;44(8):1044-52.
                    
                        
                    
                 | 
            
                        
                | 4 | 
                
                    Fevipiprant in the treatment of asthma. Expert Opin Investig Drugs. 2018 Feb;27(2):199-207.
                    
                        
                    
                 | 
            
                        
                | 5 | 
                
                    CRTH2-specific binding characteristics of [3H]ramatroban and its effects on PGD2-, 15-deoxy-Delta12, 14-PGJ2- and indomethacin-induced agonist resp... Eur J Pharmacol. 2005 Nov 7;524(1-3):30-7.
                    
                        
                    
                 | 
            
                        
                | 6 | 
                
                    Safety and efficacy of the prostaglandin D2 receptor antagonist AMG 853 in asthmatic patients.J Allergy Clin Immunol.2013 Feb;131(2):339-45.
                    
                        
                    
                 | 
            
                        
                | 7 | 
                
                    Update on the status of DP2 receptor antagonists; from proof of concept through clinical failures to promising new drugs. Expert Opin Investig Drugs. 2014 Jan;23(1):55-66.
                    
                        
                    
                 | 
            
                        
                | 8 | 
                
                    Clinical pipeline report, company report or official report of Array BioPharma (Drug: ARRY-502).
                    
                        
                    
                 | 
            
                        
                | 9 | 
                
                    Discovery and characterization of NVP-QAV680, a potent and selective CRTh2 receptor antagonist suitable for clinical testing in allergic diseases. Bioorg Med Chem. 2013 Nov 1;21(21):6582-91.
                    
                        
                    
                 | 
            
                        
                | 10 | 
                
                    Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800028464)
                    
                        
                    
                 | 
            
                        
                | 11 | 
                
                    Clinical pipeline report, company report or official report of AstraZeneca (2009).
                    
                        
                    
                 | 
            
            
            
                 | 
                 | 
                 | 
                 | 
                 | 
                 |